15:55 Jul 26
Aarti Pharmalabs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Aarti Pharmalabs Ltd.
Industry Pharmaceuticals
15:55 Jul 26
Quality
70/100
High Financial Strength
Valuation
43/100
Mid Valuation
Technical
51/100
Technically Neutral
Strength
8
Weakness
1
Opportunity
0
Threats
1
12.34 %
ROE %
8.40 %
ROA %
23.93
EPS
193.88
BVPS
11.70 %
Net Profit Margin
| Mar 2022 | Mar 2023 | Mar 2024 | ||
|---|---|---|---|---|
| Net Sales | 1199.94 | 1945.23 | 1852.61 | |
| Operating Expenses + | 993 | 1603.19 | 1466.56 | |
| Raw Material | 774.16 | 1295.12 | 1040.67 | |
| Increase Decrease in Cost | -49.05 | -125.36 | -19.95 | |
| Other Manufacturing Expense | 154.59 | 235.71 | 0 | |
| Employee Cost | 85.2 | 129.69 | 138.41 | |
| Miscellaneous Expenses | 353.94 | 629.67 | 671.87 | |
| Operating Profit | 206.94 | 342.04 | 386.05 | |
| Other Income | 2.51 | 2.32 | 4.9 | |
| Depreciation | 42.12 | 62.54 | 73.24 | |
| Interest | 11.96 | 21.05 | 17.21 | |
| Profit before tax and exceptio.. | 155.38 | 260.77 | 300.49 | |
| Exceptional Items | 0 | 0 | 0 | |
| PBT | 155.38 | 260.77 | 300.49 | |
| Provision for Taxation | 33.13 | 67.28 | 83.59 | |
| Net Profit | 122.25 | 193.49 | 216.9 | |
| NET Profit after MI | 122.25 | 193.49 | 216.9 | |
| EPS | 13.49 | 21.35 | 23.93 | |
| Operating Profit Margin (%) | 17.25 | 17.58 | 20.84 | |
| Net Profit Margin (%) | 10.19 | 9.95 | 11.71 |
ShareHolding
Promoter
FII
Public
Mutual Funds
Other Institutions
All Data in Percentage (%)
| Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | |
|---|---|---|---|---|---|
| Promoter | 46.50 | 46.50 | 46.50 | 46.30 | 46.00 |
| FII | 7.10 | 8.30 | 8.20 | 8.40 | 7.40 |
| MF | 4.70 | 2.70 | 2.00 | 2.70 | 2.70 |
| Public | 35.00 | 35.20 | 35.40 | 34.70 | 35.90 |
| Others | 6.70 | 7.30 | 7.90 | 7.90 | 8.00 |
| Shareholder | Shares | Holding % |
|---|
Download Our App On:
